Thieme E-Books & E-Journals -
Zurück
Pharmacopsychiatry 2010; 43(3): 81-85
DOI: 10.1055/s-0029-1242816
Original Paper

© Georg Thieme Verlag KG Stuttgart · New York

The Number Needed to Treat for All-Cause Medication Discontinuation in the Treatment of Schizophrenia: Consistency Across World Geographies and Study Designs

D. Novick1 , H. Ascher-Svanum2 , B. Zhu3 , A. Brnabic4 , V. Stauffer3 , X. Peng3 , J. Karagianis5 , E. Perrin6
  • 1European Outcomes Research, Eli Lilly and Co, Surrey, UK
  • 2Eli Lilly and Company, Indianapolis, Indiana, USA
  • 3Lilly USA, LLC, Indianapolis, Indiana, USA
  • 4Eli Lilly Australia Pty Ltd, Macquarie Park, Australia
  • 5Eli Lilly Canada, Toronto, Ontario, Canada, Memorial University of Newfoundland, St. John's, Newfoundland and Labrador, Canada
  • 6Eli Lilly and Company, Suresnes, France